News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,310 Results
Type
Article (2440)
Company Profile (22)
Press Release (82848)
Section
Business (35642)
Career Advice (54)
Deals (5195)
Drug Delivery (9)
Drug Development (10414)
Employer Resources (15)
FDA (1726)
Job Trends (2002)
News (50707)
Policy (2780)
Tag
Academia (181)
Accelerated approval (6)
Adcomms (3)
Allergies (16)
Alliances (3126)
ALS (8)
Alzheimer's disease (279)
Antibody-drug conjugate (ADC) (49)
Approvals (1829)
Artificial intelligence (42)
Autoimmune disease (19)
Automation (3)
Bankruptcy (23)
Best Places to Work (1819)
Biosimilars (17)
Biotechnology (13)
Bladder cancer (51)
Brain cancer (7)
Breast cancer (109)
Cancer (839)
Cardiovascular disease (70)
Career advice (48)
Career pathing (1)
CAR-T (21)
CDC (1)
Cell therapy (69)
Cervical cancer (12)
Clinical research (9776)
Collaboration (124)
Compensation (222)
Complete response letters (4)
COVID-19 (253)
CRISPR (4)
C-suite (34)
Cystic fibrosis (15)
Data (1248)
Depression (24)
Dermatology (17)
Diabetes (80)
Diagnostics (895)
Digital health (6)
Diversity, equity & inclusion (1)
Drug discovery (14)
Drug pricing (10)
Duchenne muscular dystrophy (17)
Earnings (32796)
Editorial (3)
Employer branding (3)
Employer resources (10)
Events (10521)
Executive appointments (44)
FDA (2338)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (112)
Gene editing (10)
Generative AI (6)
Gene therapy (57)
GLP-1 (134)
Government (338)
Guidances (275)
Healthcare (2492)
HIV (13)
Huntington's disease (3)
IgA nephropathy (14)
Immunology and inflammation (31)
Immuno-oncology (5)
Indications (24)
Infectious disease (293)
Inflammatory bowel disease (18)
Influenza (12)
Intellectual property (26)
Interviews (6)
IPO (3804)
IRA (2)
Job creations (269)
Job search strategy (42)
JPM (3)
Kidney cancer (6)
Labor market (25)
Layoffs (65)
Leadership (1)
Legal (452)
Liver cancer (19)
Longevity (1)
Lung cancer (137)
Lymphoma (91)
Machine learning (1)
Management (4)
Manufacturing (51)
MASH (39)
Medical device (2006)
Medtech (2014)
Mergers & acquisitions (1498)
Metabolic disorders (194)
mRNA (11)
Multiple sclerosis (18)
NASH (2)
Neurodegenerative disease (46)
Neuropsychiatric disorders (10)
Neuroscience (443)
NextGen: Class of 2026 (595)
Non-profit (367)
Now hiring (8)
Obesity (72)
Opinion (6)
Ovarian cancer (33)
Pain (24)
Pancreatic cancer (27)
Parkinson's disease (51)
Partnered (2)
Patents (49)
Patient recruitment (39)
Peanut (8)
People (2772)
Pharmaceutical (5)
Pharmacy benefit managers (3)
Phase 1 (2309)
Phase 2 (4160)
Phase 3 (3979)
Pipeline (2108)
Policy (4)
Postmarket research (366)
Preclinical (694)
Press Release (12)
Prostate cancer (43)
Psychedelics (1)
Radiopharmaceuticals (30)
Rare diseases (107)
Real estate (319)
Recruiting (6)
Regulatory (2478)
Reports (15)
Research institute (168)
Resumes & cover letters (6)
Rett syndrome (6)
RNA editing (1)
RSV (15)
Schizophrenia (22)
Series A (12)
Series B (15)
Sickle cell disease (17)
Special edition (6)
Spinal muscular atrophy (13)
Sponsored (2)
Startups (194)
Stomach cancer (3)
Supply chain (6)
Tariffs (4)
The Weekly (2)
Vaccines (94)
Venture capital (11)
Weight loss (35)
Women's health (11)
Worklife (2)
Date
Last 7 days (99)
Last 30 days (423)
Last 365 days (4920)
2026 (1190)
2025 (5097)
2024 (5858)
2023 (6457)
2022 (7675)
2021 (8029)
2020 (7457)
2019 (5498)
2018 (4241)
2017 (3887)
2016 (3168)
2015 (4109)
2014 (2910)
2013 (1768)
2012 (2244)
2011 (2702)
2010 (2233)
Location
Africa (54)
Alabama (9)
Alaska (1)
Arizona (26)
Asia (4831)
Australia (875)
California (2038)
Canada (494)
China (145)
Colorado (102)
Connecticut (76)
Delaware (83)
Europe (11117)
Florida (282)
Georgia (61)
Hawaii (1)
Idaho (3)
Illinois (120)
India (4)
Indiana (143)
Japan (77)
Kansas (14)
Kentucky (8)
Louisiana (9)
Maine (17)
Maryland (243)
Massachusetts (1337)
Michigan (44)
Minnesota (117)
Missouri (27)
Montana (2)
Nebraska (2)
Nevada (11)
New Hampshire (17)
New Jersey (763)
New Mexico (1)
New York (481)
North Carolina (262)
Northern California (1038)
Ohio (61)
Oregon (4)
Pennsylvania (551)
Puerto Rico (1)
Rhode Island (1)
South America (121)
South Carolina (6)
Southern California (849)
Tennessee (24)
Texas (329)
United States (7378)
Utah (68)
Virginia (22)
Washington D.C. (3)
Washington State (217)
Wisconsin (13)
85,310 Results for "42".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Liquid Biopsy Market to Worth USD 27.42 Billion by 2035, says Healthcare Industry Experts
December 9, 2025
·
1 min read
Press Releases
Blood Cancer Diagnostics Market Size to Hit USD 21.42 Billion by 2034
November 10, 2025
·
1 min read
Press Releases
Tessel Biosciences Awarded Up To $4.2M Through the ARPA-H CATALYST Program to Advance Drug Safety and ADMET Prediction
December 8, 2025
·
2 min read
Press Releases
Advanced Therapy Medicinal Products CDMO Market Size to Hit USD 42.25 Billion by 2034
November 4, 2025
·
1 min read
Press Releases
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
December 19, 2025
·
6 min read
Press Releases
Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
October 29, 2025
·
3 min read
Press Releases
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
September 5, 2025
·
3 min read
Drug Development
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations
Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7%. Xenon Pharmaceuticals believes this is the highest such efficacy “observed in a pivotal epilepsy study,” CEO Ian Mortimer said Monday.
March 9, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Hemostemix Granted Trademark “KNOW YOUR HEALTH” in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42
October 22, 2025
·
9 min read
1 of 8,531
Next
